Written question asked by Edward O'Hara (Labour) on Wednesday, 4 April 2001, in the House of Commons. It was due for an answer on Thursday, 26 April 2001. It was answered by Yvette Cooper (Labour) on Thursday, 26 April 2001 on behalf of the Department of Health.
Dept of Health
- Question
- To ask the Secretary of State for Health, how many cases of epilepsy have been recorded between 1st November 1999 and 28th February 2001 related to yellow cards submitted in connection with meningitis C injections; what research is being conducted into the incidence of cases of epilepsy which may be related to meningitis C injections.
- Answer
-
Mr. O'Hara: To ask the Secretary of State for Health (1) how many cases of epilepsy have been recorded between 1 November 1999 and 28 February 2001 related to yellow cards submitted in connection with meningitis C injections; [157552] (2) what research is being conducted into the incidence of cases of epilepsy which may be related to meningitis C injections. [157549] Yvette Cooper: On 1 November 1999, a national immunisation campaign commenced to vaccinate all children under 18 years with one of the new meningococcal C conjugate vaccines. The campaign finished at the end of January 2001. As of 16 February 2001, 18.5 million doses of meningitis C vaccine had been distributed. The Medicines Control Agency and the Committee on Safety of Medicine (CSM) has received three Yellow Card reports of suspected epilepsy following vaccination with the meningococcal C conjugate vaccines. A total of 291 reports of suspected seizures have been reported in association with the meningococcal C conjugate vaccines. CSM has concluded that there have been very rare reports of seizures following meningitis C vaccination and individuals have usually rapidly recovered. A significant number of the reported seizures are thought to have been faints. A report of a particular suspected adverse drug reaction does not necessarily mean that it has been caused by the drug. The Yellow Card data can not be used to calculate the incidence rate of a particular suspected adverse reaction, nor can it be used to measure changes in the rate against time. The Medical Research Council has research programmes looking into epilepsy and meningitis, but no program that is examining the incidence of epilepsy after meningococcal C conjugate vaccination.
Secondary information
- Type
- Written question
- Reference
- 367 c329W; 157552;157549
- Session
- 2000-01
- Subjects
- Epilepsy Vaccination Side effects Meningitis
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2018-07-27 03:57:16 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_673622
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_673622
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_673622